Syremis Therapeutics News and Activities

Acquisition, funding and merger involving Syremis Therapeutics.

• Syremis Therapeutics has just announced a $165 Million fundraising (posted on January 8 2026).

View the org chart displaying its 20 main executives

Most searched biographies at Syremis Therapeutics

• Elisabeth Kogan, Chief Executive Officer
• Steve Paul, Director
• Reid Huber, Director

Popular executive movements at Syremis Therapeutics

• Aaron Koenig has joined the company as Chief Medical Officer  (posted on June 18 2026).

Create your alert
to follow the executive moves at Syremis Therapeutics.

Syremis Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Syremis Therapeutics

• News Archive - Syremis Therapeutics
• Syremis Therapeutics

Social media about Syremis Therapeutics

• Syremis Therapeutics on Wikipedia, Google News & Yahoo Finance
• Syremis Therapeutics on LinkedIn, X (Twitter) & YouTube